ANDA 71918, held by Pharmobedient Cnsltg. Doxepin Hydrochloride.
As of Nov 16, 2026, ANDA 71918 (Doxepin Hydrochloride), held by Pharmobedient Cnsltg, was first approved by FDA on Jul 20, 1988, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 20, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxepin HydrochlorideEQ 10MG BASE/ML · concentrate;oral | Doxepin Hydrochloride | Discontinued |
| Jul 17, 2014 | Supplement 14Labeling · Standard review | Approved | None posted |
| Aug 13, 2008 | Supplement 12Labeling | Approved | None posted |
| Jun 26, 2007 | Supplement 10Labeling | Approved | None posted |
| Nov 5, 2001 | Supplement 8Labeling | Approved | None posted |
| Jan 11, 2001 | Supplement 7Labeling | Approved | None posted |
| Aug 17, 1995 | Supplement 6Labeling | Approved | None posted |
| Aug 17, 1995 | Supplement 5Labeling | Approved | None posted |
| Nov 24, 1993 | Supplement 4Labeling | Approved | None posted |
| Feb 12, 1992 | Supplement 3Labeling | Approved | None posted |
| Apr 2, 1991 | Supplement 2Labeling | Approved | None posted |
| Jul 20, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters